Form 4 for ENLT Enlight Renewable Energy Ltd.
Accepted 2026-05-14 07:33:35 ET · period of report 2026-05-13 · accession 0001178913-26-002668 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-05-14 07:33 | 2026-05-13 | ENLT | Yavetz Gilad | EXEC. COB, Dir | M - OptEx | $23.22 | +77.2K | 967.2K | +9% | +$1.79M |
| D | 2026-05-14 07:33 | 2026-05-13 | ENLT | Yavetz Gilad | EXEC. COB, Dir | F - Tax | $91.78 | -20.7K | 946.4K | -2% | -$1.90M |
| DM | 2026-05-14 07:33 | 2026-05-13 | ENLT | Yavetz Gilad | EXEC. COB, Dir | S - Sale+OE | $91.78 | -100.0K | 846.4K | -11% | -$9.18M |
| D | 2026-05-14 07:33 | 2026-05-13 | ENLT | Yavetz Gilad | EXEC. COB, Dir | M - OptEx | $0.00 | -77.2K | 275.0K | -22% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Ordinary shares, NIS 0.1 par value per share | 2026-05-13 | M | A | 77,210 | $23.22 | 967,157.10 | D | — | — | (F1) Represents an exercise price of NIS 71.89, converted to U.S. dollars using the Bank of Israel representative exchange rate of $1.00 to NIS 3.096 as of March 18, 2026. (F2) Includes (i) 43,512 restricted share units granted on April 17, 2024, with 21,756 vesting on each of April 17, 2027 and April 17, 2028; and (ii) 6,726 restricted share units granted on October 1, 2025, with 1,681 vesting on October 1, 2026, 1,682 vesting on October 1, 2027, 1,681 vesting on October 1, 2028, and 1,682 vesting on October 1, 2029. Each restricted share unit represents a contingent right to receive one ordinary share of the Company. |
| 2 | Common | Ordinary shares, NIS 0.1 par value per share | 2026-05-13 | F | D | 20,721 | $91.78 | 946,436.10 | D | — | — | (F3) These shares were retained by the Company in payment of the exercise price of the employee stock options exercised by the Reporting Person. The amount retained by the Company was not in excess of the amount of the exercise price. (F4) Represents a transaction price of NIS 267.00, converted to U.S. dollars using the Bank of Israel representative exchange rate of $1.00 to NIS 2.909 as of the date immediately preceding the date of the transaction. (F2) Includes (i) 43,512 restricted share units granted on April 17, 2024, with 21,756 vesting on each of April 17, 2027 and April 17, 2028; and (ii) 6,726 restricted share units granted on October 1, 2025, with 1,681 vesting on October 1, 2026, 1,682 vesting on October 1, 2027, 1,681 vesting on October 1, 2028, and 1,682 vesting on October 1, 2029. Each restricted share unit represents a contingent right to receive one ordinary share of the Company. |
| 3 | Common | Ordinary shares, NIS 0.1 par value per share | 2026-05-13 | S | D | 56,489 | $91.78 | 889,947.10 | D | — | — | (F4) Represents a transaction price of NIS 267.00, converted to U.S. dollars using the Bank of Israel representative exchange rate of $1.00 to NIS 2.909 as of the date immediately preceding the date of the transaction. (F2) Includes (i) 43,512 restricted share units granted on April 17, 2024, with 21,756 vesting on each of April 17, 2027 and April 17, 2028; and (ii) 6,726 restricted share units granted on October 1, 2025, with 1,681 vesting on October 1, 2026, 1,682 vesting on October 1, 2027, 1,681 vesting on October 1, 2028, and 1,682 vesting on October 1, 2029. Each restricted share unit represents a contingent right to receive one ordinary share of the Company. |
| 4 | Common | Ordinary shares, NIS 0.1 par value per share | 2026-05-13 | S | D | 43,511 | $91.78 | 846,436.10 | D | — | — | (F4) Represents a transaction price of NIS 267.00, converted to U.S. dollars using the Bank of Israel representative exchange rate of $1.00 to NIS 2.909 as of the date immediately preceding the date of the transaction. (F2) Includes (i) 43,512 restricted share units granted on April 17, 2024, with 21,756 vesting on each of April 17, 2027 and April 17, 2028; and (ii) 6,726 restricted share units granted on October 1, 2025, with 1,681 vesting on October 1, 2026, 1,682 vesting on October 1, 2027, 1,681 vesting on October 1, 2028, and 1,682 vesting on October 1, 2029. Each restricted share unit represents a contingent right to receive one ordinary share of the Company. |
| 5 | Derivative | Stock Options (right to buy) | 2026-05-13 | M | D | 77,210 | $0.00 | 274,997 | D | $23.22 · — to 2028-09-30 | 77,210 Ordinary shares, NIS 0.1 par value per share | (F1) Represents an exercise price of NIS 71.89, converted to U.S. dollars using the Bank of Israel representative exchange rate of $1.00 to NIS 3.096 as of March 18, 2026. (F5) Stock options were granted on September 30, 2021, with 24,997 having vested on September 30, 2023, 50,000 having vested on December 30, 2023, 50,000 having vested on March 30, 2023, 50,000 having vested on June 30, 2023, 50,000 having vested on September 30, 2024, 12,500 having vested on December 30, 2024, 12,500 having vested on March 30, 2025, 12,500 having vested on June 30, 2025, and 12,500 having vested on September 30, 2025. (F5) Stock options were granted on September 30, 2021, with 24,997 having vested on September 30, 2023, 50,000 having vested on December 30, 2023, 50,000 having vested on March 30, 2023, 50,000 having vested on June 30, 2023, 50,000 having vested on September 30, 2024, 12,500 having vested on December 30, 2024, 12,500 having vested on March 30, 2025, 12,500 having vested on June 30, 2025, and 12,500 having vested on September 30, 2025. |